Product NDC: | 63323-474 |
Proprietary Name: | Haloperidol |
Non Proprietary Name: | HALOPERIDOL LACTATE |
Active Ingredient(s): | 5 mg/mL & nbsp; HALOPERIDOL LACTATE |
Administration Route(s): | INTRAMUSCULAR |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63323-474 |
Labeler Name: | APP Pharmaceuticals, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075689 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110328 |
Package NDC: | 63323-474-01 |
Package Description: | 25 VIAL in 1 TRAY (63323-474-01) > 1 mL in 1 VIAL |
NDC Code | 63323-474-01 |
Proprietary Name | Haloperidol |
Package Description | 25 VIAL in 1 TRAY (63323-474-01) > 1 mL in 1 VIAL |
Product NDC | 63323-474 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | HALOPERIDOL LACTATE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR |
Start Marketing Date | 20110328 |
Marketing Category Name | ANDA |
Labeler Name | APP Pharmaceuticals, LLC |
Substance Name | HALOPERIDOL LACTATE |
Strength Number | 5 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Typical Antipsychotic [EPC] |